Trimel’s sexual disorder drug effective in mid-stage studyReuters(Reuters) – Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in women with an orgasmic disorder in a second mid-stage study. The company said its lowest tested dose of 0.6 mg of the nasal …Trimel Pharma’s sexual disorder drug effective in mid-stage studyReuters Indiaall 6 news articles …Read Full Story
Trimel's sexual disorder drug effective in mid-stage study - Reuters
Real Estate of Cebu
